Atkins Michael B. bought HOWL
January 4, 2024 · Form 4 insider transaction
Atkins Michael B. bought 35,000 shares of Werewolf Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,000
Price
$0.00
Total value
N/A
InsiderAtkins Michael B.
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 4, 2024
Filing dateJanuary 4, 2024
Shares owned after35,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted on January 4, 2024. The shares underlying the option vest over three years, with one-third of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter.